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Abstract 
Human SP-B is synthesized by the alveolar Type II epithelial cell as a 381 amino acid preproprotein. The 79 residue mature SP-B 
peptide is extremely hydrophobic and flanked by propeptides of 200 and 102 amino acids at its NH 2- and COOH-termini, respectively. 
The purpose of this study was to identify peptide domains of the SP-B proprotein ecessary for trafficking of the mature peptide in the 
secretory pathway. To this end several constructs were generated, by subcloning the full length human SP-B (SP-B), COOH-terminally 
truncated SP-B (SP-Bao in which residues 201-381 were deleted), NH2-terminally deleted SP-B (SP-BaN, in which residues 28-200 
were deleted), NH2-terminal propeptide (SP-BN), mature SP-B (SP-B M) and COOH-terminal propeptide (SP-Bc), into the mammalian 
expression vector pcDNA3. The resulting expression constructs were characterized by DNA sequencing and in vitro transcription/transla- 
tion and subsequently transfected into Chinese hamster ovary cells. 48 h after transfection, cells were labeled with [35S]-met/cys and 
analyzed by immunoprecipitation, SDS-PAGE and autoradiography. Proteins encoded by SP-B, SP-Bac, SP-B N and SP-B c constructs 
were secreted into media; in contrast, SP-B constructs lacking the NH2-terminal propeptide (SP-BaN) remained in the endoplasmic 
reticulum (as assessed by endoglycosidase H sensitivity) and were rapidly degraded. We conclude that (1) 27 amino acids at the 
NH2-terminus of SP-B contain a functional signal peptide and (2) the NHz-terminal propeptide of the SP-B precursor is necessary and 
sufficient for intracellular t afficking of the mature peptide. 
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1. Introduction 
Pulmonary surfactant is a complex mixture of phospho- 
lipids and proteins which is synthesized and secreted by 
the alveolar Type II epithelial cell [ 1-3]. Surfactant spreads 
as a monomolecular film along the surface of the alveolar 
epithelium and plays a critical role in maintaining the 
structural integrity of the alveolus during respiratory ex- 
pansion and contraction. Pulmonary surfactant protein B 
(SP-B) is one of several ung-specific proteins associated 
with surfactant phospholipids. Mutations of the SP-B gene 
that result in a complete absence of SP-B protein are 
invariably fatal shortly after birth supporting the impor- 
tance of this peptide for surfactant function [4,5]. We have 
recently shown that ablation of the SP-B gene in mice 
disrupts the routing, storage and function of surfactant 
phospholipids and proteins, causing respiratory failure at 
birth [6]. 
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Human SP-B is synthesized by the Type II epithelial 
cell as a 381 amino acid preproprotein. Processing of the 
precursor protein within the secretory pathway results in 
cleavage of the signal peptide, followed by proteolytic 
cleavage of the NH2-terminal (177 amino acids) and 
COOH-terminal (102 amino acids) propeptides to generate 
the biophysically active, mature peptide of 79 residues 
[7-9]. Proteolytic processing of the proprotein occurs in an 
endosomal/lysosomal compartment, the multivesicular 
body, prior to incorporation of the mature peptide into the 
lamellar body [10], which is secreted in response to an 
appropriate extracellular stimulus. 
The mature SP-B peptide is very hydrophobic, consist- 
ing of approx. 60% non-polar amino acids. In addition, 
SP-B is positively charged and has been shown to promote 
aggregation, disruption and fusion of liposomes containing 
negatively charged phospholipids [11,12]. The potential of 
SP-B to disrupt lipid membranes suggests that the mature 
peptide must be escorted through the secretory pathway 
prior to association with surfactant phospholipids. The 
present study was undertaken to identify peptide domains 
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that facilitate intracellular transport of the mature SP-B. 
The results of this study demonstrate hat the NH~-termi- 
nal propeptide of SP-B is both necessary and sufficient o 
direct constitutive secretion of the hydrophobic, mature 
peptide. 
inhibitors, including PMSF, leupeptin, aprotinin, and pep- 
statin A and cell culture media (DMEM and F-12 media) 
were purchased from Sigma Chemical Co. (St. Louis, 
MO). 
2.2. Cell culture 
2. Materials and methods 
2.1. Materials 
Restriction endonucleases and pfu polymerase were 
purchased from Stratagene (La Jolla, CA). T4 DNA ligase 
and alkaline phosphatase were purchased from New Eng- 
land BioLabs (Beverly, MA). Endoglycosidase H and F 
were purchased from Boehringer Mannheim Biochemicals 
(Indianapolis, IN). Penici l l in/streptomycin and 
trypsin/EDTA were purchased from Gibco Laboratories 
(Grand Island, NY). [3~S]-met/cys (spec. act. = Ci/mmol) 
was obtained from DuPont (Boston, MA). [35S]-met (spec. 
act. Ci/mmol) was purchased from Amersham (Arlington 
Heights, IL). Protein G-Sepharose was obtained from 
Zymed Laboratories (San Francisco, CA). All protease 
Chinese hamster ovary (CHO) K-1 cells (obtained from 
the American Type Culture Collection, Rockville, MD) 
were grown at 37°C, 5% CO 2, in F-12 medium supple- 
mented with 10% FBS, 100 U/ml penicillin, and 100 
p.g/ml streptomycin. 
2.3. Generation of recombinant SP-B antigens 
Four different antisera directed against SP-B were used 
in this study: Antiserum 28031 was raised against the 
mature SP-B peptide isolated from chloroform-methanol 
extracts of bovine lung lavage [13,14] and subsequently 
purified to homogeneity by the method of Suzuki et al. 
[15]; Antiserum 55522 was generated against the full 
length human recombinant SP-B; Antisera 55019 and 
96189 were raised against 200 residue and 102 residue 
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Fig. 1. Generation and characterization of SP-B antisera. A. Purification of recombinant SP-B. Recombinant SP-B proprotein and propeptides were 
expressed in bacteria nd purified, as described in METHODS, subjected to electrophoresis and stained with Coomassie Blue. Lane 1, SP-B proprotein, 
M r = 42000. Lane 2, NH2-terminal propeptide, M r = 20000. Lane 3, COOH-terminal peptide, M r = l 1 000. Molecular weight markers are indicated at the 
right of the panel, in kDa. B. Immunoblot analysis of antisera directed against NH 2- and COOH-terminal peptides of SP-B. AtT-20 cells were transfected 
with the full length human SP-B cDNA cloned into the mammalian expression vector pcDNA3. Transfected (lanes 1, 3 and 5) and non-transfected (lanes 2, 
4 and 6) AtT-20 cell lysates were subjected to electrophoresis, transferred to nitrocellulose, and immunoblotted with antisera 96189 (directed against 
COOH-terminal peptide, lanes 1 and 2), 55522 (directed against full length SP-B proprotein, lanes 3 and 4) and 55019 (generated against NHa-terminal 
peptide, lanes 5 and 6). C. Immunoblot analysis of antiserum directed against mature SP-B. Type II cell lysates (lane 1), transfected (lane 2) and 
non-transfected (lane 3) AtT-20 cell lysates were subjected to electrophoresis, transferred tonitrocellulose, and immunoblotted. Antiserum 28031 detected 
SP-B, M r = 8000, in Type II cells and M r = 42000, in AtT-20 cells transfected with full length human SP-B construct. 
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Fig. 2. SP-B constructs. The human SP-B gene encodes a preproprotein of 381 amino acids, M r = 42 000 [36], which includes a predicted 23 residue signal 
peptide (sp), a 177 residue NH2-terminal propeptide (NH2), a 79 residue mature peptide (SP-B) and a 102 residue COOH-terminal propeptide (COOH). A 
consensus sequence for the addition of complex-type asparagine-linked oligosaccharide is present at residues 129 and 311 in the NH 2- and COOH-terminal 
propeptides, respectively [37]. All inserts were generated by PCR and cloned into the mammalian expression vector pcDNA3. The resulting constructs 
were subsequently transfected into CHO cells and analyzed by immunoprecipitation of labeled cell lysates and media (Figs. 4-7). 
recombinant peptides corresponding to the NH 2- and 
COOH-terminal propeptides of human SP-B, respectively. 
Recombinant antigens were produced as fusion proteins 
containing a hexahistidine tag by cloning the appropriate 
coding sequence of human SP-B into the bacterial expres- 
sion vector pRSET A (Invitrogen, San Diego, CA). SP-B 
constructs were transformed into E. coli strain JM109 and 
expression of recombinant protein induced by the addition 
of 1 mM IPTG. Three hours later, the bacterial pellet was 
isolated, lysed in 6 M guanidine, 20 mM Tris, 0.5 M NaC1 
and recombinant SP-B purified by chromatography on 
Ni-NTA agarose (QIAGEN, Chatsworth, CA), as de- 
scribed by the supplier. All recombinant peptides were 
subsequently dialyzed against phosphate-buffered saline 
(137 mM NaC1, 5.4 mM Na2HPO 4, 2.7 mM KC1, 1.8 mM 
KH2PO 4, pH 7.2), quantitated by the method of Lowry 
Table 1 
Templates and primers used in PCR reactions for generation of SP-B constructs 
SP-B constructs PCR primers a Templates 
5'-primers b Y-primers c 
SP-B 1-7 376-381 SP-B eDNA 
SP-Bac 1-7 275-279 SP-B eDNA 
SP-B N 1-7 196-200 SP-B eDNA 
SP-Ba N(SMC) PCR I (sp * ) 1-7 23-27(201-205) SP-B eDNA 
PCR 1I (SP-B + COOH) (23-27)201-205 376-381 SP-B cDNA 
PCR lII 1-7 376-381 PCR I + PCR II 
SP-Ba A N(SCM) PCR I (sp) 1-7 23-27(280-284) SP-B eDNA 
PCR II (COOH * ) (23-27)280-284 377-381(201-205) SP-B cDNA 
PCR HI (SP-B * ) (377-381)201-205 275-279 SP-B eDNA 
PCR IV 1-7 275-279 PCR I + PCR II + PCR III 
SP-BM 1-7 275-279 SP-BaN(SMC) 
SP-B c 1-7 376-381 SP-BaN(SCM )
a Numbers refer to amino acid residues encoded by the human SP-B eDNA (Genbank accession umber M24461). Numbers in parentheses indicate 
sequence added to the primer in order to generate a complementary overlap for assembly in the combined PCR. 
b In order to facilitate cloning and translation an EcoRI restriction site followed by the Kozak sequence (TGCC) was incorporated into the 5'-end of each 
external primer (ACTAGCGAATTCTGCC). 
c In order to facilitate cloning and expression a XhoI restriction site following two stop codons (TCATCA) was incorporated into the Y-end of each 
external primer (ATACCGCTCGAGTCATCA). 
sp = signal peptide; SP-B = mature peptide; COOH = COOH-terminal propeptide. 
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[16] and the purity of the preparation assessed by SDS- 
PAGE and silver or Coomassie Blue staining (Fig. 1A). 
2.4. Generation of  SP-B antisera 
Approx. 500 Ixg of the purified SP-B in Freund's 
incomplete adjuvant was injected (i.m.) into rabbits every 
2 wk for up to six months. Sera were collected after the 
first three injections and screened and titered by enzyme- 
linked immunoabsorbent assay (ELISA) using the appro- 
priate recombinant antigens. Antisera were further charac- 
terized by immunoblotting of cell lysates from untrans- 
fected AtT-20 cells and AtT-20 cells stably transfected 
with full length human SP-B cDNA (cloned into the 
mammalian expression vector pcDNA3) and by immuno- 
precipitation of [35S]-met/cys labeled cell lysates from 
both transfected and non-transfected AtT-20 cells (Fig. 
1B). The specificity of each antibody was confirmed by 
competition experiments with recombinant SP-B, as previ- 
ously described for synthetic SP-B peptides [17]. 
2.5. DNA constructs and transfection 
All procedures involving oligonucleotide and cDNA 
manipulations were performed essentially as described in 
Sambrook et al. [18]. The seven constructs (Fig. 2) were 
generated by subcloning the appropriate SP-B coding se- 
quences into the Eco RI and Xho I sites of the mammalian 
expression vector pcDNA3 (Invitrogen, San Diego, CA), 
which contains the human cytomegalovirus (CMV) pro- 
moter and neo-resistance g ne. All constructs, including 
the full length human SP-B (SP-B), COOH-terminally 
truncated SP-B (SP-Bac), NH2-terminally deleted SP-B 
(SP-BaN(SMC) = signal peptide + mature peptide + COOH- 
terminal peptide; SP-BAN(SCM) = signal peptide + COOH- 
terminal peptide + mature peptide), NH2-terminal peptide 
(SP-BN), COOH-terminal peptide (SP-B c) and mature 
peptide (SP-BM), were generated by polymerase chain 
reaction (PCR) (Table 1). Purified pUC18 vector contain- 
ing the full length human SP-B cDNA and pcDNA3 vector 
containing SP-BaN(SMC ) or SP-BAN(SCM) sequence were 
used as template for the PCR. NH2-terminal deletion 
(SP-BaN(SMC)) mutagenesis was performed using four 
primer-mediated recombinant PCR in which PCR products 
1 and 2 were mixed and joined by means of complemen- 
tary tails on the internal primers [19]. Heteroduplexes with 
recessed 3' ends were filled in by pfu polymerase, and the 
combined PCR1-PCR2 product was amplified using the 
external primers; a similar procedure was used to generate 
the SP-BaN(SCM ) construct, with the exception that six 
primers were required (Table 1). The resulting constructs 
were sequenced in both directions through the entire cod- 
ing region and the open reading frame was further charac- 
terized by in vitro transcription/translation usi g TNT T7 
coupled reticulocyte lysate system, exactly as described by 
the supplier (Promega, Madison, WI). No mutations were 
detected by sequencing and each construct was efficiently 
transcribed and translated in vitro. All seven expression 
plasmids were subsequently transiently transfected into 
CHEWY cells using the standard calcium phosphate proce- 
dure [18]. Transfection efficiency was monitored by analy- 
sis of enzyme activity resulting from co-transfection of
plasmid encoding the reporter molecule 13-galactosidase; in 
some experiments (e.g. expression of SP-BaN and SP-B M) 
expression efficiency was monitored by co-transfection 
with plasmid encoding the SP-B proprotein followed by 
immunoprecipitation of both the proprotein and the dele- 
tion constructs as described below. Each transfection ex- 
periment was repeated at least three times for every con- 
struct. 
2.6. Metabolic labeling and immunoprecipitation 
48 h after transient transfection, cells were equilibrated 
for 45 min in methionine-deficient a d cysteine-deficient 
MEM followed by a 4 h label in the presence of 1 mCi/ml 
[35S]-met/cys. The medium was collected and the cells 
lysed in solubilization buffer (60 mM Tris, pH 7.4, 190 
mM NaC1, 6 mM EDTA and 4% SDS) followed by the 
addition of 1 vol of water and 4 vol of dilution buffer (50 
mM "Iris, pH 7.4, 190 mM NaC1, 6 mM EDTA and 2.5% 
Triton X-100). The medium and cell lysates were pre- 
cleared with 5 izl of normal rabbit serum and 30 izl of a 
1:1 suspension of recombinant protein G-Sepharose at 4°C 
overnight. Protein G-Sepharose complexes were removed 
by centrifugation and 5 I~1 of the appropriate SP-B anti- 
serum and 30 I~1 of Protein G-Sepharose were added to the 
supernatant and incubated at 4°C overnight. Protein G-anti- 
body-SP-B protein complexes were collected by centrif- 
ugation in a microcentrifuge and washed four times with 
Wash Buffer I (50 mM Tris, pH 7.5, 100 mM NaC1, 5 mM 
EDTA, 0.1% Triton X-100, 0.2% SDS) and twice with 
Wash Buffer II (Buffer I without detergents). The pellet 
was resuspended in 15 ~zl of electrophoresis ample buffer 
(60 mM Tris, pH 6.8, 2% SDS, 10% glycerol, 5% 2-mer- 
captoethanol, 0.01% bromophenol blue), heated at 100°C 
for 4 min, centrifuged for 1 min and the supernatant 
applied to a 10-20% polyacrylamide minigel (Integrated 
Separation Systems, Natick, MA). SDS-PAGE was per- 
formed according to the method of Laemmli [20]. Gels 
were fixed in 40% methanol, 10% acetic acid and 3% 
glycerol for 60 min, soaked in Enlightning (DuPont, 
Boston, MA) containing 3% glycerol for 30 min and dried 
at 60°C for 60 min; dried gels were exposed to Kodak 
XAR2 film at -80°C. 
2.7. Endoglycosidase H and F digestion 
Endoglycosidase F digestion was performed to confirm 
the presence of asparagine-linked oligosaccharides. Endo- 
glycosidase H digestion was performed in order to localize 
glycoproteins encoded by each SP-B construct to the early 
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or late secretory pathway: Endoglycosidase H sensitive 
forms are present in the endoplasmic reticulum whereas 
endoglycosidase H resistant forms are restricted to the 
Golgi and post-Golgi compartments. Immunoprecipitated, 
washed SP-B bound to protein G-Sepharose was resus- 
pended in 100 mM sodium acetate buffer (pH 5.5) contain- 
ing 0.1% NP-40, 1 mM PMSF, 1 mM EDTA, 100 ~M 
leupeptin, 10 i~g/ml pepstatin, and 2 txg/ml aprotinin. 
The samples were divided into two equal aliquots and 
incubated in the absence or presence of 0.1 U/ml  endogly- 
cosidase H. For endoglycosidase F digestion immuno- 
precipitated SP-B was suspended in 100 mM sodium 
phosphate buffer (pH 6.2) containing 0.1% NP-40, 10 mM 
EDTA, protease inhibitors and 2 units/ml of the enzyme. 
After overnight digestion, SP-B was recovered by centrif- 
ugation and prepared for electrophoresis as described 
above. 
1 2 
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3. Results 
Four polyclonal antisera were generated for use in the 
present study. The purity of the immunizing antigens was 
assessed by Coomassie Blue staining (Fig. 1A) or silver 
staining and NH2-terminal amino acid sequence analyses 
(not shown) following SDS-PAGE: Each purified, recom- 
binant protein preparation consisted of more than 90% 
SP-B with minor bacterial protein contamination; prepara- 
tion of mature, native peptide isolated from bovine lavage, 
contained only SP-B, as assessed by silver staining (not 
shown). All four antisera generated against hese antigens 
detected the SP-B proprotein by immunoblotting (Fig. 1B 
and C) or immunoprecipitation (not shown) of transfected 
AtT-20 cells. The specificity of each immunoreaction was 
confirmed by immunoblotting untransfected cells (Fig. 1B 
and C) and by competition with the appropriate recombi- 
nant or native antigen (not shown). Antiserum 28031 also 
detected the mature SP-B peptide but not SP-C (M r < 6000) 
in immunoblots of rat Type II epithelial cell lysates (Fig. 
1C) and rat alveolar lavage fluid (not shown). Antiserum 
55522 detected both the NH 2- and COOH-terminal 
propeptides but did not recognize the mature SP-B (not 
shown). Antisera 55019 and 96189 were specific for the 
NH 2- and COOH-terminal propeptides respectively. These 
crude antisera were used for analyses of SP-B deletion 
constructs expressed in CHO cells and in vitro transcrip- 
tion/translation assays. 
To determine if mature SP-B could traffick through the 
secretory pathway, the sequence ncoding the NH 2- and 
COOH-terminal propeptides was deleted from the human 
SP-B cDNA (Fig. 2). The resulting construct encoded a 
protein consisting of a 27 amino acid signal peptide se- 
quence fused to the 79 residue mature peptide. Immuno- 
precipitation and SDS-PAGE of the products of in vitro 
transcription/translation detected mature SP-B as an 
oligomer which was reduced to the monomer form follow- 
Fig. 3. In vitro transcription/translation of SP-B mature peptide. A 
plasmid, encoding the SP-B signal peptide and mature peptide, was 
transcribed and translated in vitro in rabbit reticulocyte lysate and im- 
munoprecipitated with antiserum 28031. The primary translation products 
were detected as oligomers, Mr= 16000 and 24000, following elec- 
trophoresis in the absence of 2-mercaptoethanol (lane 1), and were 
reduced to the monomer form, M r = 8000, in the presence of 2-mercapto- 
ethanol (lane 2). Protein standards are shown at the right of the panel, in 
kDa. 
ing electrophoresis in the presence of 2-mercaptoethanol 
(Fig. 3). Transient ransfection of CHO cells with the 
SP-B M construct resulted in very low or undetectable 
expression of mature SP-B despite the fact that expression 
of the co-transfected SP-B proprotein construct was readily 
detected (not shown). These results suggest hat, in the 
absence of the flanking propeptides, mature SP-B is ineffi- 
ciently translocated into the endoplasmic reticulum and/or 
rapidly degraded. 
In order to determine if the SP-B M construct encoded a
functional signal peptide, a construct consisting of the 
sequence ncoding the 27 amino acid signal peptide (re- 
sidues 1-27) and the COOH-terminal propeptide (residues 
280-381) was transfected into CHO cells. Following label- 
ing and immunoprecipitation, theCOOH-terminal propep- 
tide was readily detected in both cells and media (Fig. 4). 
The secreted protein was completely resistant to endogly- 
cosidase H digestion (not shown) and was extensively 
modified by covalent attachment of oligosaccharide to 
asparagine at position 311, as demonstrated by sensitivity 
to endoglycosidase F digestion (Fig. 4, lane 4). The results 
of these experiments indicate that the COOH-terminal 
propeptide contains information ecessary for its own fold- 
ing and that the first 27 amino acids at the NH E-terminus 
of the SP-B preproprotein encode a functional signal pep- 
tide; further, these results suggest that the consistently ow 
level/undetectable of SP-B M expression in transfected 
CHO cells was related to properties of the mature peptide 
rather than to a non-functional signal sequence. 
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Fig. 4. The COOH-terminal propeptide is secreted by CHO cells. Cells 
transiently transfected with SP-B c were labeled with [ 35 S]-met/cys for 4 
h, and cell lysates (C) and media (M) immunoprecipitated with antiserum 
96189. Immunoprecipitated proteins bound to protein G-Sepharose were 
incubated with (lanes 2 and 4) or without (lanes 1 and 3) endoglycosidase 
H or F followed by SDS-PAGE in the presence of 2-mercaptoethanol. 
COOH-terminal propeptide, M r = l 1 000, was detected in cells as an 
endoglycosidase H sensitive form (lanes 1 and 2). SP-B propeptide 
secreted into media was heterogeneous with respect to size but was 
largely sensitive to endoglycosidase F digestion (lanes 3 and 4). Immuno- 
reactive protein was not detected in untransfected cells or media (not 
shown). 
-43  
-29 
~:iii!iiiiiiii!iiiiiiiiiiiii!iiiiiii!i ~ 
-18 
-14 
Fig. 5. SP-B and SP-Bac are secreted by CHO cells. CHO cells trans- 
fected with SP-B and SP-B~c constructs were labeled with [35S]-met/cys 
for 4 h, and the media immunoprecipitated with antiserum 28031. SP-B 
was secreted both in the absence (lane 1) and presence (lane 2) of the 
COOH-terminal propeptide. Mol. wt. standards are indicated at the right 
of the panel, in kDa. 
To determine if the COOH-terminal propeptide is re- 
quired for transit of SP-B in the secretory pathway, the 
sequence ncoding 102 residues of the COOH-terminus of 
the SP-B proprotein was deleted (Fig. 2). Transient rans- 
fection of CHO cells followed by labeling and immuno- 
precipitation demonstrated that expression of SP-Bac was 
readily detectable in both cells and media (Fig. 5). Pulse- 
chase experiments in stably transfected CHO cells indi- 
cated that SP-Bac was rapidly secreted with kinetics simi- 
lar to those for CHO cells stably transfected with the 
preproprotein construct (not shown). For both SP-B pro- 
protein and SP-Bac, intracellular SP-B was endoglycosi- 
dase H sensitive throughout the entire chase period indicat- 
ing that the rate of secretion was limited by transport out 
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Fig. 6. SP-BaN is not secreted by CHO cells. Two constructs, SP-BAN(SMC ) and SP-BaN(SCM ), were generated by deletion of the sequence ncoding 
residues 28-200 of the preproprotein, as described in Section 2 and Fig. 2. A. In vitro transcription/translation. Expression plasmids were transcribed and 
translated in vitro, followed by immunoprecipitation with antiserum 55522. Primary translation products were separated by SDS-PAGE in the presence of 
2-mercaptoethanol. Proteins encoded by SP-BaN(SMC ) (lane 1) and SP-BaN(SCM ) (lane 2) had identical amino acid compositions and were translated with 
equal efficiency, but migrated differently during electrophoresis. B Transient expression of SP-BaN(SMC ) in CHO cells. Cells transfected with 
SP-BaN(SMC ) were labeled with [35S]-met/cys for 4 h and cell lysates and media immunoprecipitated with antiserum 55522. Immunoprecipitated proteins 
bound to protein G-Sepharose were incubated with or without endoglycosidase H and subjected to SDS-PAGE in the presence of 2-mercaptoethanol. 
SP-BaN(SMC ), M r = 20000, was detected only in cells. Approximately 75% of the SP-BaN(SMC ) was not glycosylated, consistent with inefficient 
translocation i to the endoplasmic reticulum; all of the glycosylated SP-B, M r = 23 000, was sensitive to endoglycosidase H. C. Transient expression of 
SP-BaN(scM ) in CHO cells. Cells transfected with SP-BaN(SCM ) were labeled with [35S]-met/cys for 4 h and cell lysates and media immunoprecipitated 
with antiserum 55522. SP-BaN(SCM ) was not detected in media and barely detectable in cells (bottom arrowhead); expression of co-transfected SP-B 
proprotein was readily detectable (top arrowhead). 
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of the endoplasmic reticulum. These results suggest hat 
the COOH-terminal propeptide of SP-B is not required for 
folding of the proprotein or for intracellular transport of 
the mature peptide. 
To determine if the NH 2-terminal propeptide was abso- 
lutely required for intracellular transport of SP-B, the 
sequence ncoding residues 28-200 of the preproprotein 
was deleted to generate a construct encoding the signal 
peptide, mature peptide and COOH-terminal propeptide 
(SP-B~N(SMC)) (Fig. 2). Because this construction resulted 
in the juxtaposition of two relatively hydrophobic se- 
quences (signal peptide and mature peptide), a second 
construct encoding the signal peptide, COOH-terminal 
propeptide and mature peptide (SP-BaN(SCM)) was also 
generated. These constructs were transcribed and translated 
in vitro with equal efficiency; however, despite identical 
amino acid compositions (verified by nucleic acid se- 
quence analyses), SP-BaN(SCM ) migrated slightly faster 
than SP-BaN(SMC ) on SDS-PAGE (Fig. 6A). Following 
transient ransfection of CHO cells, expression of SP- 
BaN(SMC ) was detected as an endoglycosidase H sensitive 
form in cell lysates (Fig. 6B). Prolonged autoradiographic 
exposure (10x longer than SP-Bac) detected very small 
amounts of SP-BaNtSMC ) in the media; however, in contrast 
to secreted forms of SP-B (SP-B, SP-Bac, SP-B N and 
SP-Bc), extracellular SP-BaN(sMC ) was endoglycosidase H 
sensitive and therefore likely the result of cell lysis rather 
than secretion. Similar to SP-BAN(SMC ), expression of the 
SP-BaN(SCM ) construct was very difficult to detect in CHO 
cells despite the fact that expression of co-transfected 
[3-galactosidase or SP-B proprotein was readily detected 
(Fig. 6C), consistent with rapid intracellular degradation of 
the protein; however, as for SP-BaN(SMC ), the SP-BaN~SCM ) 
protein was not secreted and was detected only as the 
endoglycosidase H sensitive form in CHO cells (not 
shown). These results suggest that the NH2-terminal 
propeptide is required for intracellular transport of the 
mature peptide. 
In order to determine if the NH2-terminal propeptide 
alone could be folded and secreted by CHO cells, the 
sequence ncoding residues 201-381 was deleted from the 
SP-B cDNA to generate a construct encoding the signal 
peptide followed by the NI-I 2-terminal propeptide (SP-B N). 
Following transient transfection of CHO cells, the propep- 
tide was detected in both cells and media (Fig. 7). The 
kinetics of NH2-terminal propeptide secretion were slightly 
faster than those for the proprotein most likely because of 
reduced folding complexity (not shown). The secreted 
propeptide was detected as 4-5 peptides, with M r = 20- 
25 000 (Fig. 7, lane 1); treatment with endoglycosidase F 
resulted in accumulation of peptide with M r = 20 000 (not 
shown), indicating that the size heterogeneity was largely 
related to glycosylation of asparagine at position 129. 
Intracellular SP-B (Fig. 7, lane 2) was less heterogeneous 
than the secreted propeptide (Fig. 7, lane 1) and was 
sensitive to endoglycosidase F (Fig. 7, lane 3), suggesting 
1 2 3 
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Fig. 7. The NH2-terminal propeptide is secreted by CHO ceils. CHO cells 
transfected with SP-B N were labeled with [35S]-met/cys for 4 h and 
media (M) and cell lysates (C) immunoprecipitated with antiserum 
55019. Immunoprecipitates were incubated with (lane 3) or without (lanes 
1 and 2) endoglycosidase F, and proteins analyzed by electrophoresis in 
the presence of 2-mercaptoethanol. Both secreted (M) and intracellular 
(C) NH2-terminal propeptides were heterogeneous with respect to size, 
M r = 20000-25000. Intracellular (lane 3) and secreted (not shown) SP-B 
were sensitive toendoglycosidase F. Protein standards are shown on the 
right of the panel, in kDa. 
that extensive modification of the oligosaccharide tree 
occurs late in the secretory pathway. Overall secretion of 
the NH2-terminal propeptide, in the absence of any other 
SP-B sequence, indicates that all of the information re- 
quired for intracellular transport of the mature SP-B is 
contained within the propeptide. 
4. Discussion 
Trafficking of SP-B within the secretory pathway of the 
Type II epithelial cell can be divided into three discrete 
steps: (1) folding of the proprotein within the endoplasmic 
reticulum and subsequent transport to the Golgi; (2) recog- 
nition of targeting determinants in the proprotein that 
direct SP-B away from the constitutive secretory pathway 
to the lamellar body and (3) proteolytic processing of the 
proprotein and coincident assembly of the mature peptide 
with surfactant phospholipids. The present study focused 
to the identification of peptide domains required for intra- 
cellular transport of SP-B. Mature SP-B is an hydrophobic 
peptide that promotes aggregation and fusion of lipid 
vesicles in the presence of calcium and anionic phospho- 
lipids. Given the propensity of the mature peptide to 
interact with lipids, it is highly likely that intracellular 
transport of this molecule requires association with a hy- 
drophilic intramolecular chaperone. The results of the pre- 
sent study demonstrate hat the NH2-terminal propeptide 
of SP-B fulfills this role and is both necessary and suffi- 
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cient for trafficking of the mature peptide in the secretory 
pathway. 
All SP-B deletion constructs used in the present study 
were analyzed for their ability to direct secretion of SP-B 
when expressed in CHO cells. CHO cells do not normally 
express SP-B and do not proteolytically process trans- 
fected SP-B proprotein to the mature peptide [7]; therefore, 
background ue to endogenous SP-B expression is elimi- 
nated and the number of secreted forms of SP-B is mini- 
mized. Further, CHO cells do not contain a regulated 
secretory pathway and secretion-competent SP-B is there- 
fore rapidly (constitutively) secreted into the media; in 
contrast, secretion-incompetent pro eins become trapped in 
the endoplasmic reticulum and are detected as endogly- 
cosidase H sensitive forms only in the cells. In order to 
ensure that the secretion phenotype was the result of a 
specific peptide deletion, each SP-B construct was care- 
fully analyzed for sequence fidelity, the open reading 
frame was confirmed by in vitro translation of the encoded 
protein and successful transfection of CHO cells was 
confirmed by co-transfection with a reporter molecule. 
Proteins destined for secretion require a signal sequence 
to mediate translocation i to the endoplasmic reticulum 
[21]. The SP-B signal peptide used in these studies was 
based on von Heijne's rules [22], which predicts an NH 2- 
terminally located sequence of 23 residues, and included 4 
amino acids of the NH2-terminal propeptide to preserve 
any structural context hat might affect translocation effi- 
ciency. The observation that the 27 residue signal sequence 
was sufficient to direct efficient translocation of the 
COOH-terminal propeptide, as evidenced by glycosylation 
and secretion, indicates that the first 27 residues of the 
SP-B preproprotein contain a fully functional signal pep- 
tide. These results suggest hat lack of SP-B secretion in 
the absence of the NH2-terminal propeptide was not re- 
lated to a non-functional signal peptide. 
In order to identify the propeptide(s) required for intra- 
cellular trafficking of the mature SP-B, deletion constructs 
of the proprotein were transiently expressed in CHO cells 
and cell lysates and media analyzed by immunoprecipita- 
tion. Deletion of the NH2-terminal propeptide (SP- 
BaN~SMC )) resulted in slightly higher levels of intracellular 
SP-B relative to mature peptide (SP-B M) alone, consistent 
with increased stabilization of SP-B. SP-BAy~SMC) was 
glycosylated indicating successful translocation into the 
endoplasmic reticulum; however, secreted, endoglycosi- 
dase H resistant forms were never detected indicating that 
the COOH-terminal propeptide was not sufficient o chap- 
erone the mature peptide through the secretory pathway. In 
contrast o these results, deletion of the COOH-terminal 
propeptide (SP-Bac) resulted in expression and secretion 
of SP-B comparable to that detected for the transfected 
wild type preproprotein dicating that the NH2-terminal 
propeptide was sufficient for intracellular transport and 
secretion of the mature SP-B. 
Although clearly required for mature peptide traffick- 
ing, it is less clear if the NH2-terminal propeptide directs 
folding of the mature peptide. Propeptide-mediated fol ing 
has been described for a large number of proproteins 
including ot-lytic protease, yeast Proteinase A and subtil- 
isin, which contain propeptides of 166, 54 and 77 amino 
acids respectively [23-25]. In each case the propeptide 
could act in trans to facilitate folding of the mature protein. 
In contrast to these proproteins, some of the aspartic 
proteinases, including cathepsin D [26] and renin [27], fold 
efficiently in the absence of their propeptides. The role of 
the NH 2-terminal propeptide in folding of the mature SP-B 
was not evaluated in the present study because SP-B was 
expressed at low levels and because the proprotein was not 
proteolytically processed to the biophysically active pep- 
tide in CHO cells. 
In addition to facilitating intracellular transport, the 
NH2-terminal propeptide may regulate oligomeric-depen- 
dent functions of SP-B. The mature SP-B peptide is recov- 
ered from the airway primarily in the dimeric form. Jo- 
hanssen et al. [28,29] have demonstrated that both human 
and porcine SP-B contain three intrachain disulfide bridges 
in addition to an intermolecular disulfide bridge, con- 
tributed by cysteine 48 of the mature peptide. Formation of 
sulfhydryl-dependent oligomers occurs rapidly when the 
sequence ncoding the mature peptide is transcribed and 
translated in vitro; in contrast, all constructs containing the 
NH2-terminal propeptide failed to dimerize following in 
vitro transcription/translation or expression i  CHO cells. 
These results suggest that dimerization of SP-B occurs late 
in the secretory pathway, after proteolytic processing of 
the proprotein in the multivesicular bodies. While 
oligomerization of most secretory proteins occurs in the 
endoplasmic reticulum, mouse hepatitis virus M protein 
has recently been shown to oligomerize in the trans- 
Golgi/trans-Golgi network, an event which may constitute 
part of the signal required for retention in this compart- 
ment [30]. The functional significance of SP-B oligomer- 
ization is unknown but may affect sorting within the 
secretory/endocytic pathways of the Type II cell or alter 
the biophysical properties of the mature peptide. 
There are an increasing number of examples in which 
propeptides also act as sorting signals within the secretory 
pathway. The sequence QRPL in the propeptide of 
carboxypeptidase Y has been shown to mediate sorting to 
the vacuolar compartment of yeast [31]. Likewise 26 amino 
acids of the POMC propeptide are sufficient o target CAT 
to secretory vesicles in AtT-20 cells [32,33]. However, a 
role for the SP-B NH2-terminal propeptide in targeting to 
lamellar bodies in Type II cells seems less likely. Process- 
ing of the SP-B proprotein occurs within multivesicular 
bodies and although the mature peptide is subsequently 
routed to lamellar bodies neither the NH 2-terminal nor the 
COOH-terminal propeptides are detected in this compart- 
ment [8,10]. It is therefore possible that the mature peptide 
itself contains information ecessary for targeting SP-B to 
the regulated secretory pathway of Type II epithelial cells. 
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The fate the NH 2- and COOH-terminal propeptides i
not entirely clear. When transiently expressed in CHO 
cells, both propeptides are rapidly glycosylated and se- 
creted. However, propeptide secretion is not detected in 
vivo, suggesting that, in the Type II epithelial cell, the 
propeptide is segregated from the mature peptide following 
processing in the multivesicular bodies. Interestingly, both 
the NH 2- and COOH-terminal propeptides each contain an 
approx. 80 residue motif with striking structural homology 
to the saposins, lysosomal peptides that facilitate glycol- 
ipid catabolism [34]. The presence of saposin-like domains 
within the SP-B propeptides, the ability of the propeptides 
to traffick independently in the secretory pathway (results 
of this study) and the importance of the Type II epithelial 
cell in clearance of surfactant lipids from the airway 
support he concept hat one or both propeptides may play 
an important role in lipid turnover in Type II cells. 
Although many hormones, zymogens and other secre- 
tory proteins are expressed as proproteins relatively little is 
known about the function of their propeptides [25,35]. In 
the case of SP-B, the NH 2-terminal propeptide is clearly 
required for intracellular transport of the biophysically 
active, hydrophobic, mature peptide. Whether this propep- 
tide has other functions will require further investigation i
cells that contain a regulated secretory pathway or in 
transgenic mice. 
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